home / stock / acst:cc / acst:cc short
Short Information | Acasti Pharma Inc. (TSXVC:ACST:CC)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 0 |
Total Actual Volume | 0 |
Short Trends | |
---|---|
Cover Days | 0 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 0 |
Average Short Percentage | 0.00% |
Is there a ACST:CC Short Squeeze or Breakout about to happen?
See the ACST:CC Short Analysis for free Sign up or Login
Powered by Squeeze Report
News, Short Squeeze, Breakout and More Instantly...
PRINCETON, N.J., June 27, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel injectable formulation of nimodipine that addresses high unmet medical needs for a rare disease, aneurysmal subarachnoid hemor...
Patient Enrollment in Pivotal STRIVE-ON Phase 3 Safety Trial for GTX-104 On-Track for Potential NDA Submission in 1H Calendar 2025 Projected Cash Runway into Second Calendar Quarter 2026 PRINCETON, N.J., June 21, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (...
PRINCETON, N.J., May 28, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel, injectable formulation of nimodipine that addresses high unmet medical needs for a rare disease, aneurysmal subarachnoid hemor...